AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2014
Jun 6, 2014
30583_dirs_2014-06-06_4d2fd166-0972-4a0e-be54-2f0d8007be15.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2014-06-04
Reporting Person: LAWLIS V BRYAN (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-06-04 | Common Stock | A | 2100 | — | Acquired | 11800 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-06-04 | Stock Option (right to buy) common stock | $63.10 | A | 6600 | Acquired | 2024-06-03 | Common Stock (6600) | Direct |
Footnotes
F1: Restricted stock units granted on June 4, 2014. Price not applicable.
F2: Option grant vests 1/4 on September 4, 2014 and 1/4th every 90 days thereafter.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19